Regeneron Pharmaceuticals Incorporated
General
Cases7
Challenger50%
Patent Owner50%
NPE50%
--
--
Practice Areas
Biotech
Top Attorneys
Elite Ratings
DCTPTABCAFC
Analytics
Lawyers
Cases
Ratings Trends
Practice Areas
Recent Dockets
Entered | Case | Description |
---|---|---|
09/16/24 | ORDER of USCA for the Federal Circuit as to [259] Notice of Appeal filed by Samsung Bioepis Co., Ltd., [190] Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., [258] Notice of Appeal filed by Samsung Bioepis, CO., LTD., [175] Notice of Appeal, filed by Samsung Bioepis, CO., LTD., [203] Notice of Appeal, filed by Formycon AG, 261 Notice of Appeal filed by Formycon AG, [176] Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024) | |
07/16/24 | USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING: re 258 in 1:24-md-03103-TSK-JPM and 268 in 1:23-cv-00094-TSK-JPM. Notice of Appeal filed by Samsung Bioepis, CO., LTD. Federal Circuit USCA Case Number: 2024-2083. (snc) (Entered: 07/16/2024) | |
07/16/24 | USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING: re 250 in 1:23-cv-00106-TSK-JPM and 259 in 1:24-md-03103-TSK-JPM. Notice of Appeal filed by Samsung Bioepis Co., Ltd. Federal Circuit USCA Case Number: 2024-2082. (snc) (Entered: 07/16/2024) | |
06/17/24 | SO ORDERED Granting 1098 Joint Stipulation to Substitute Party and Amend Case Caption. Signed by Judge Richard G. Andrews on 6/17/2024. (nms) (Entered: 06/17/2024) | |
08/03/21 | REPORT ON THE DETERMINATION OF AN ACTION Regarding a Patent or Trademark. (Closing) (Attachments: # [1] Order Granting Joint Motion to Dismiss) (gk) (Entered: 08/03/2021) | |
08/03/21 | REPORT ON THE DETERMINATION OF AN ACTION Regarding a Patent or Trademark. (Closing) (Attachments: # 1 Order Granting Joint Motion to Dismiss) (gk) (Entered: 08/03/2021) | |
08/03/21 | ORDER GRANTING JOINT MOTION TO DISMISS by Judge Andre Birotte Jr.: The parties joint motion to dismiss pursuant to Federal Rule of Civil Procedure 4l(a)(2) and (c) 402 is GRANTED. All of Immunexs claims as to Defendants in the action are hereby DISMISSED WITH PREJUDICE. All of Defendants counterclaims in the action are hereby DISMISSED WITHOUT PREJUDICE. As the prevailing party, Defendants shall be entitled to their costs amounting to $39,811.80 to be paid to Defendants within 30 days of the Courts order of dismissal. Each party shall bear its own attorneys fees. ( MD JS-6. Case Terminated ) (gk) (Entered: 08/03/2021) |